KCL R&D CENTER

KCL was established in 2007 to develop products and technologies based on the collagen molecule. For this purpose, we aim to develop the collagen ecosystem by developing projects that evaluate the leather industry products, waste, and by-products as new value-added products. KCL Research Focus is Divided into Three Main Areas; KCL BIOMATERIALS: We are developing innovative biomaterials from animal tissue wastes for tissue engineering, biomedicine, regenerative medicine, and bioprinting applications. The company bases its activity on its technology creation and has obtained patents for two product families, with more applications pending. KCL HEALTH & NUTRITION: Our team, which conducts research in this field, work to develop alternative food and food additives from waste products. In addition, the development of new protein sources using biotechnological methods and their use for nutritional purposes are also in our fields of interest. KCL LEATHER & TECHNOLOGY: We work to make the leather industry a non-polluting industry that recycles all of its waste and produces with the principle of zero waste. Re-evaluation of wastes in production, alternative bio-solutions to replace substances prohibited by REACH regulation, and circular economy are among our working areas. KCL R&D has its own offices, laboratories with top-of-the-line equipment, and a pilot plant for chemical synthesis and fertilizer production. Our laboratories’ equipment to synthesize, characterize and process bio-polymers and advanced composites; laboratories are completely equipped for process and characterization concerning the funded project background. KCL is currently involved in 2 Eureka projects, 1 of them coordinated by KCL, and has participated in more than 25 TUBITAK-funded projects.